These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 7585512

  • 21. Expression of alpha-catenin in alpha-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures.
    Matsubara S, Ozawa M.
    Oncogene; 2004 Apr 08; 23(15):2694-702. PubMed ID: 14755240
    [Abstract] [Full Text] [Related]

  • 22. Reduced alpha-catenin and E-cadherin expression in breast cancer.
    Rimm DL, Sinard JH, Morrow JS.
    Lab Invest; 1995 May 08; 72(5):506-12. PubMed ID: 7745946
    [Abstract] [Full Text] [Related]

  • 23. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
    Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH.
    Int J Oncol; 2002 Jul 08; 21(1):135-44. PubMed ID: 12063560
    [Abstract] [Full Text] [Related]

  • 24. Transition from the noninvasive to the invasive phenotype and loss of alpha-catenin in human colon cancer cells.
    Vermeulen SJ, Bruyneel EA, Bracke ME, De Bruyne GK, Vennekens KM, Vleminckx KL, Berx GJ, van Roy FM, Mareel MM.
    Cancer Res; 1995 Oct 15; 55(20):4722-8. PubMed ID: 7553655
    [Abstract] [Full Text] [Related]

  • 25. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer.
    Mareel M, Vleminckx K, Vermeulen S, Yan G, Bracke M, van Roy F.
    Princess Takamatsu Symp; 1994 Oct 15; 24():63-80. PubMed ID: 8983064
    [Abstract] [Full Text] [Related]

  • 26. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
    Tomlinson JS, Alpaugh ML, Barsky SH.
    Cancer Res; 2001 Jul 01; 61(13):5231-41. PubMed ID: 11431364
    [Abstract] [Full Text] [Related]

  • 27. Decreased expression of E-cadherin in the progression of rat prostatic cancer.
    Bussemakers MJ, van Moorselaar RJ, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FM, Schalken JA.
    Cancer Res; 1992 May 15; 52(10):2916-22. PubMed ID: 1581909
    [Abstract] [Full Text] [Related]

  • 28. Molecular biology of prostate cancer.
    Isaacs WB, Bova GS, Morton RA, Bussemakers MJ, Brooks JD, Ewing CM.
    Semin Oncol; 1994 Oct 15; 21(5):514-21. PubMed ID: 7939745
    [Abstract] [Full Text] [Related]

  • 29. Cadherin and catenin alterations in human cancer.
    Hajra KM, Fearon ER.
    Genes Chromosomes Cancer; 2002 Jul 15; 34(3):255-68. PubMed ID: 12007186
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
    Menke A, Philippi C, Vogelmann R, Seidel B, Lutz MP, Adler G, Wedlich D.
    Cancer Res; 2001 Apr 15; 61(8):3508-17. PubMed ID: 11309315
    [Abstract] [Full Text] [Related]

  • 31. E-cadherin transfection down-regulates the epidermal growth factor receptor and reverses the invasive phenotype of human papilloma virus-transfected keratinocytes.
    Wilding J, Vousden KH, Soutter WP, McCrea PD, Del Buono R, Pignatelli M.
    Cancer Res; 1996 Nov 15; 56(22):5285-92. PubMed ID: 8912870
    [Abstract] [Full Text] [Related]

  • 32. Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.
    Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.
    Hepatology; 2002 Sep 15; 36(3):692-701. PubMed ID: 12198663
    [Abstract] [Full Text] [Related]

  • 33. The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice.
    Vijayakumar S, Garcia D, Hensel CH, Banerjee M, Bracht T, Xiang R, Kagan J, Naylor SL.
    Genes Chromosomes Cancer; 2005 Dec 15; 44(4):365-72. PubMed ID: 16080199
    [Abstract] [Full Text] [Related]

  • 34. Suppression of human prostate cancer cell growth by forced expression of connexin genes.
    Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, Roos BA.
    Dev Genet; 1999 Dec 15; 24(1-2):91-110. PubMed ID: 10079514
    [Abstract] [Full Text] [Related]

  • 35. Four human breast cancer cell lines with biallelic inactivating alpha-catenin gene mutations.
    Hollestelle A, Elstrodt F, Timmermans M, Sieuwerts AM, Klijn JG, Foekens JA, den Bakker MA, Schutte M.
    Breast Cancer Res Treat; 2010 Jul 15; 122(1):125-33. PubMed ID: 19763817
    [Abstract] [Full Text] [Related]

  • 36. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T.
    Cancer Res; 1996 Sep 01; 56(17):4063-70. PubMed ID: 8752180
    [Abstract] [Full Text] [Related]

  • 37. Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis.
    Nam JS, Ino Y, Sakamoto M, Hirohashi S.
    Clin Cancer Res; 2002 Jul 01; 8(7):2430-6. PubMed ID: 12114449
    [Abstract] [Full Text] [Related]

  • 38. Altered localization of E-cadherin and alpha-catenin in rat esophageal tumors.
    Khare L, Sabourin CL, De Young BR, Jamasbi RJ, Stoner GD.
    Int J Oncol; 1999 Jan 01; 14(1):33-40. PubMed ID: 9863006
    [Abstract] [Full Text] [Related]

  • 39. E-cadherin mediated adhesion system in cancer cells.
    Shiozaki H, Oka H, Inoue M, Tamura S, Monden M.
    Cancer; 1996 Apr 15; 77(8 Suppl):1605-13. PubMed ID: 8608551
    [Abstract] [Full Text] [Related]

  • 40. [Dysfunction of cadherin cell adhesion system in cancer invasion and metastasis].
    Ochiai A.
    Gan To Kagaku Ryoho; 1999 Mar 15; 26(4):565-71. PubMed ID: 10097760
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.